I think it's good. Viburnum seems to have made up their mind to largely exit (which itself is bad) but if one views this year and next as a bit of a windfall (could easily generate $60m revenue over the 2 years) why not buy back 20% of the company for a couple of million?
If they can't or won't trim costs (staff and leases) to the new reality of (likely) significantly reduced revenues from 2026 and beyond then they'll be in strife (to the point of potential extinction) but IF they can manage the transition effectively then it's an absolute bargain.
If they end the year with a healthy net cash balance, good 2025 enrolments and a determination to manage costs then some of the negative commentary on these threads will start to look a little silly.
Having said that, I'm still shocked at how poorly the new ESOS allocations appear to have been calculated and assigned. I had a bit of a look at the full list and at face value there are some terrible anomalies. It doesn't seem as though sufficient effort has been made to reward or protect reputable providers over time and/or providers of essential training (however those may be defined).
Despite the certainty of some on this thread I'm still hopeful there might be some room for amendments or adjustments after the submissions and hearings on October 2.
EDU Price at posting:
6.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)